Teprotumumab is a human monoclonal antibody that blocks the IGF-1 receptor (IGF-1R). Teprotumumab binds to the extracellular alpha-subunit domain ligand of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab reduces TSH-dependent I
CAS Number:
[1036734-93-6]
Target:
TSH Receptor|||IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted